Routine lab tests often include HbA1c, fasting glucose, insulin levels (HOMA-IR), lipid panels, and kidney function tests
Clinical trials showed HbA1c reductions of roughly 1.3% to 1.6%, placing it within the range expected for GLP-1 receptor agonists currently used in diabetes care
These may be mild and temporary, but they can also interfere with hydration, nutrition, work, exercise, or daily comfort
The steady inclusion of GLP-1s and SGLT2s has directed prescribing practices, away from the longstanding reliance on older, generic drugs
Many patients find that gradually reducing fat intake and choosing leaner proteins, low-fat dairy options, and cooking methods like baking, grilling, or steaming rather than frying can improve tolerance